Subang Jaya Medical Centre ( SJMC ) at dusk
• Image-guided radiation therapy ( IGRT )
• Intensity-modulated radiation therapy ( IMRT )
• Intraoperative radiation therapy ( IORT )
• Stereotactic Body Radiotherapy ( SBRT )
• Stereotactic Radiosurgery ( Frameless )
• Stereotactic Radiotherapy
• TACE – Transarterial Chemo Embolization
• Volumetric Arc Therapy ( VMAT ) or RapidArc ® Radiotherapy Technology
The combination of quality imaging capabilities within the radiotherapy treatment systems allows precise matching of daily treatment with the planned treatment . This resulted in
high patient survival outcomes that established SJMC ’ s position as one of the best globally .
Excellence in Clinical Outcomes SJMC conducts clinical studies to determine cancer survival rates of patients who seek treatment at the hospital . The award-winning hospital has published two papers on its cancer survival rates with the aim to compare its performance with national and international cancer care providers , continuously measure its cancer care performance and help improve its services to patients .
This year , the hospital earned its title as the winner of GlobalHealth Award for Advanced Genetic Service Provider of the Year in the Asia-Pacific in its second year running .
“ We take pride in our world-class proven clinical outcomes from published works which demonstrate that the breast cancer relative survival rate ( all stages ) is 90 % and nasopharyngeal cancer relative survival rate ( all stages ) is 73.2 %. This puts us on the world map in the field and delivers the best possible outcomes for our patients not just locally , but regionally too ,” said Catherine Lee , Director of Cancer & Radiosurgery Centre .
In 2020 , a collaboration between SJMC doctors and Cancer Research Malaysia scientists with the University of Cambridge , UK built the largest genetic and genomic database of Asian breast cancers to date . This significant milestone helps doctors to diagnose patients more precisely and offers the most effective treatment option , espe-
50 SEPTEMBER 2022 GlobalHealthAsiaPacific . com